U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07293728) titled 'A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia' on Dec. 17.
Brief Summary: This is an open-label, randomized feasibility trial in which patients admitted to Oregon Health & Science University (OHSU) after a pregnancy complicated by preeclampsia who are considering a progestin-only pill contraception postpartum will be randomized to norethindrone or drospirenone for 6 weeks following hospital discharge.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Hypertension
Preeclampsia
Intervention:
DRUG: Norethindrone 0.35 MG
1 tablet (0....